MENU
+Compare
GERN
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$1.42
Change
+$0.02 (+1.44%)
Capitalization
904.42M

GERN Geron Corp Forecast, Technical & Fundamental Analysis

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments... Show more

Industry: #Biotechnology
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for GERN with price predictions
Apr 23, 2025

Momentum Indicator for GERN turns positive, indicating new upward trend

GERN saw its Momentum Indicator move above the 0 level on April 22, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned positive. In of the 97 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GERN's RSI Oscillator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GERN just turned positive on April 11, 2025. Looking at past instances where GERN's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where GERN advanced for three days, in of 226 cases, the price rose further within the following month. The odds of a continued upward trend are .

GERN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GERN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GERN entered a downward trend on April 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GERN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.227) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (11.919) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. GERN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GERN is expected to report earnings to fall 20.00% to -3 cents per share on May 07

Geron Corp GERN Stock Earnings Reports
Q1'25
Est.
$-0.03
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.04
Q2'24
Est.
$-0.10
Q1'24
Beat
by $0.03
The last earnings report on February 26 showed earnings per share of -3 cents, missing the estimate of -2 cents. With 5.33M shares outstanding, the current market capitalization sits at 904.42M.
A.I. Advisor
published General Information

General Information

a developer of therapeutic products for cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
919 East Hillsdale Boulevard
Phone
+1 650 473-7700
Employees
141
Web
https://www.geron.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VTRIX38.41N/A
N/A
Vanguard International Value Inv
IICAX10.09N/A
N/A
AMF Large Cap Equity AMF
SBPYX33.08N/A
N/A
ClearBridge Small Cap Growth I
SLCAX13.90N/A
N/A
SEI Large Cap A (SIIT)
AINTX15.68N/A
N/A
Ariel International Investor

GERN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GERN has been loosely correlated with SER. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if GERN jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GERN
1D Price
Change %
GERN100%
-2.84%
SER - GERN
66%
Loosely correlated
+5.09%
LIANY - GERN
53%
Loosely correlated
-5.10%
VCYT - GERN
44%
Loosely correlated
+1.08%
MIRM - GERN
39%
Loosely correlated
+0.42%
NRIX - GERN
37%
Loosely correlated
+1.31%
More